Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

BMC cancer

Volumn 13, Issue , 2013, Pages

  Kim, Stefano ^b   Dobi, Erion ^b   Jary, Marine ^b   Monnien, Franck ^b   Curtit, Elsa ^b   Nguyen, Thierry ^b   Lakkis, Zaher ^b   Heyd, Bruno ^b   Fratte, Serge ^b   Cléau, Denis ^b   Lamfichekh, Najib ^b   Nerich, Virginie ^b   Guiu, Boris ^b   Demarchi, Martin ^b   Borg, Christophe ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGPT2 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAMPTOTHECIN; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; KAPLAN MEIER METHOD; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; LIVER NEOPLASMS; MIDDLE AGED; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84897019821     PISSN: None     EISSN: 14712407     Source Type: None    
DOI: 10.1186/1471-2407-13-611     Document Type: Article

References (0)